Summary
For Year 2026-27, Aarti Drugs reports the following shareholding: Total Promoters at 55.03%, Mutual Fund at 10.14%, Insurance at 0.08%, Foreign Institutional Investors at 1.57%, Domestic Institutional Investors at 0.01%, and Retail at 33.18%. This breakdown provides a quick snapshot of ownership distribution for Aarti Drugs in 2026-27.
Aarti Drugs FAQs
As of 04-2026, the promoter shareholding in Aarti Drugs stands at 55.03% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Aarti Drugs is 1.57% and 0.01% respectively.
The retail shareholding of the Aarti Drugs is 33.18%.
Changes in shareholding patterns of Aarti Drugs can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Aarti Drugs are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
